Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Aug 6, 2026, during market hours
10-Q filed Aug 6, 2026, 37 days after period end · 0001193125-26-337933
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $6.18M | $6.20M |
| Net Income | -$16.64M | -$52.62M | -$14.58M | -$17.97M |
| EPS Diluted |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| -$0.20 |
| -$0.76 |
| -$0.54 |
| -$0.67 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.